Objective-The mechanisms underlying abdominal aortic aneurysm development remain unknown. We hypothesized that acceleration of glucose metabolism with the upregulation of glucose transporters is associated with abdominal aortic aneurysm development. Methods and Results-Enhanced accumulation of the modified glucose analogue 18 fluoro-deoxyglucose by positron emission tomography imaging in the human abdominal aortic aneurysm was associated with protein expressions of glucose transporters-1 and -3, assessed by Western blot. The magnitude of glucose transporter-3 expression was correlated with zymographic matrix metalloproteinase-9 activity. Intraperitoneal administration of glycolysis inhibitor with 2-deoxyglucose significantly attenuated the dilatation of abdominal aorta induced by periaortic application of CaCl 2 in C57BL/6J male mice or reduced the aneurysmal formation in angiotensin II-infused apolipoprotein E knockout male mice. In monocytic cell line induced by phorbol 12-myristate 13-acetate or ex vivo culture obtained from human aneurysmal tissues, 2-deoxyglucose abrogated the matrix metalloproteinase-9 activity and interleukin-6 expression in these cells/tissues. Moreover, 2-deoxyglucose attenuated the survival/proliferation of monocytes and the adherence of them to vascular endothelial cells. Conclusion-This study suggests that the enhanced glycolytic activity in aortic wall contributes to the pathogenesis of aneurysm development. In addition, pharmacological intervention in glycolytic activity might be a potential therapeutic target for the disorder.
M etabolic activity controls cell fate, in which glucose is a major energy source and is also an important substrate for both protein and lipid synthesis in mammalian cells; however, dysregulation of glucose metabolism contributes to the pathogenesis of various disorders, such as cancer, degenerative disease, metabolic syndrome, or infection. 1 Specifically, cancer cells display high rates of aerobic glycolysis, whereas increased glycolysis is also a function of many inflammatory conditions. 2, 3 One or more transport systems allow glucose to move either into or out of these cells, mostly taken up from interstitial fluid, mediated by the family of passive, facilitative glucose transporters (gene symbol SLC2A, protein symbol GLUT), 4 and subsequently, advances the glycolytic pathway initially catalyzed by hexokinases. Abdominal aortic aneurysm (AAA) is a relatively common disorder among elderly people, which is characterized by atherosclerosis of the intima and disruption or attenuation of the elastic media with various degrees of adventitial inflammatory cell infiltration. 5, 6 Although the mechanisms underlying AAA development, progression, and rupture are complex, chronic inflammation of the aortic wall is suggested to be involved in the pathogenesis. [6] [7] [8] The rupture rate increases as the aneurysm grows, 6 and vulnerability of the aneurysmal wall is associated with medial neovascularization and the activation of matrix-degrading enzymes, matrix metalloproteinases (MMPs). [9] [10] [11] In particular, MMP-9 appears to be critical for the aneurysm development and rupture. 9, 12 At present, surgical intervention is the only proven strategy to prevent the rupture risk. Therefore, a better understanding of the pathophysiology of AAA and development of effective pharmacological therapies to inhibit/attenuate the expansion of AAA warrants investigation. Recent studies have shown that modified glucose analogue 18 fluoro-deoxyglucose (18F-FDG) is accumulated in atherosclerosis-based AAA, [13] [14] [15] [16] [17] implying a link between inflammation and glycolysis in the pathogenesis of AAA development. We hypothesized that acceleration of glucose metabolism with the upregulation of
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GLUT is associated with AAA development. In this study, we first characterized the glycolytic activity using positron emission tomography (PET)/computed tomography in human AAA. Second, we explored whether the inhibition of glycolytic activity is a valid target for AAA. 
Materials and Methods

results
Patients' characteristics, 18F-FdG uptake, Zymographic Gelatinase Abundance, and expressions of GluT in Human AAA
The characteristics of patients enrolled in this study are shown in Table I in the online-only Data Supplement. Figure 1A illustrates that AAA patients tended to have increased 18F-FDG uptake assessed by maximum standardized uptake value (SUVmax) in carotid arteries, ascending aorta, aortic arch, and common iliac artery compared with age-matched subjects. Moreover, 18F-FDG uptake was significantly increased in the descending aorta, the abdominal aorta just below the origin of renal arteries and the maximal aneurysmal site in patients with AAA. Examples of 18F-FDG-PET/computed tomography scan are shown in Figure I in the online-only Data Supplement. The magnitudes of zymographic gelatinase abundance, corresponding to MMP-2, MMP-9, and protein expressions of GLUT-1 to GLUT-4 were quite variable between the respective samples, whereas MMP-9 abundance tended to increase in the proximal transition zone of the aneurysmal aorta ( Figure II in the online-only Data Supplement). Figure  1B -1F illustrates the correlation of SUVmax or zymographic MMP-9 abundance and GLUT-1, GLUT-3 expressions with the representative gelatin zymogram, and Western blots. The SUVmax obtained from PET-computed tomography was Figure 1 . A, 18F-FDG uptake in abdominal aortic aneurysm (AAA) patients (n17) and in age-matched non-AAA patients (n23). Maximum standardized uptake value (SUVmax) normalized to body weight was described for the respective sites of the aorta (1, right carotid artery; 2, left carotid artery; 3, ascending aorta; 4, aortic arch; 5, descending aorta; 6, just below the origin of renal arteries; 7, maximal diameter of aneurysm or corresponding site of abdominal aorta; and 8, common iliac artery). Open column, age-matched non-AAA patients; closed column, AAA patients. Data are expressed as means±SEM. *P,0.05, **P,0.01 vs age-matched non-AAA patients. B and C, Relationship between SUVmax and protein expressions for glucose transporter (GLUT)-1 (B) and GLUT-3 (C). D and E, Relationship between zymographic matrix metalloproteinase (MMP)-9 abundance and GLUT-3 (D) or GLUT-1 (E) expressions. F, Representative Western blot images for GLUT-1 to GLUT-4 and gelatin zymogram (1, proximal transition zone; 2, maximal site of AAA; and 3, nondilated common iliac artery). -actin was used as the protein-loading control. G, Immunohistochemical staining of red blood cells positive for glycophorin A, macrophages positive for CD68, GLUT-1, and GLUT-3 and their merge. Immunofluorescent images were taken photographs from the square areas (1 for glycophorin A; 2 for CD68) of aneurysmal wall. (HE, hematoxylin-eosin. Scale bar: 200 µm for HE (original magnification, X40); 50 µm for immunofluorecent images). OI indicates optical intensity; L, latent form; A, active form.
associated with the magnitude of protein expressions for GLUT-1 (n35, r50.706, P0.0001, Figure 1B ), GLUT-3 (n35, r0.415, P0.013, Figure 1C ) at the corresponding site, but this was not the case with GLUT-2 (n35, r-0.227, P0.190) or GLUT-4 (n35, r0.122, P0.484). In addition, the active form of zymographic MMP-9 abundance was associated with the magnitude of GLUT-3 (n35, r0.375, P0.024, Figure 1D ), but not with GLUT-1 protein expression (n35, r0.139, P0.419, Figure 1E ). There was no correlation between latent and active forms of zymographic MMP-2 abundance and GLUT-1 to GLUT-4 expressions ( Figure III in the online-only Data Supplement). As shown in Figure 1G , the cellular localization of GLUT-1 in the AAA specimen appeared abundantly in red blood cells exuded in the aneurysmal wall and macrophages, whereas GLUT-3 immunoreactivity was specifically localized in macrophages. Neither GLUT-1 nor GLUT-3 immunoreactivity was detected in T-lymphocytes or mast cells (data not shown).
expression of GluT in Monocytic cell line
GLUT-1 and GLUT-3 were predominantly expressed in monocytic cell line U937 among GLUT-1 to GLUT-4 ( Figure   2A ). Stimulation of U937 cells with phorbol 12-myristate 13-acetate (PMA) induced maturation, resulting in macrophage-like phenotypes, capable of synthesizing MMP-9. 18 Accordingly, PMA (10 nmol/L) induced a marked increase in zymographic MMP-9 abundance ( Figure 2B and 2C), whereas PMA led to a significant increase in the expression levels of GLUT-3 mRNA (4.9-fold) and protein (2.0-fold) compared with untreated cells, respectively ( Figure 2B , 2D, and 2E). Conversely, PMA caused minimal change to the GLUT-1 level in these cells.
effect of Glycolysis restriction on Aneurysm development in Murine Models of AAA
Increased diameter of the abdominal aorta after the periaortic application of CaCl 2 was accompanied by the temporal upregulation in the protein expressions of GLUT-1, GLUT-3, and zymographic MMP-9 abundance (Figure IVA-IVD in the online-only Data Supplement). GLUT-1 immunoreactivity was widely distributed, including F4/80-positive macrophages and fibroblasts in the adventitia, whereas GLUT-3 was specifically found in some F4/80-positive macrophages at day 7 after the periaortic application of CaCl 2 ( Figure IVE in the onlineonly Data Supplement). Figure 3A and 3B shows that intraperitoneal administration of glucose analogue, 2-deoxyglucose (DG) 19 significantly attenuated the dilatation of the abdominal aorta induced by periaortic application of CaCl 2 at day 28. This was accompanied by the preservation of elastin fibers in the media ( Figure 3A and 3C), decreases in the numbers of inflammatory cells, such as macrophages, T-lymphocytes, and mast cells in the adventitial layer ( Figure 3D -3F), and reduced expressions of zymographic MMP-9 abundance, GLUT-1, GLUT-3, and monocyte chemotactic protein (MCP)-1 ( Figure  3G -3I). Figure 4A shows that protein expression of GLUT-1 was decreased in apolipoprotein E knockout mice infused by angiotensin II at day 28 compared with that at day 7, regardless of aneurysmal formation; whereas the GLUT-3 expression was increased in the nonaneurysmal aorta at day 28 compared with those at day 7 and was further increased in the presence of aneurysm. Figure 4B and 4C shows that 2-DG administration to the apolipoprotein E knockout mice infused by angiotensin II for 28 days significantly (P0.024) attenuated the aneurysmal formation, accompanied by reducing the number of macrophages accumulated at the adventitia and the expressions of GLUT-3, MMP-9, and MCP-1. The macrophage number accumulated at the adventitia was associated with the aortic diameter (n28, r0.426, P0.024). As shown in Figure 4D , both GLUT-1 and GLUT-3 immunoreactivity were detected in the aneurysmal wall at the suprarenal aorta in which GLUT-1 was widely distributed, whereas some GLUT-3 was identical to F4/80-positive macrophages. Conversely, the immunoreactive distribution was decreased by the 2-DG administration. Figure 5A shows that 2-DG significantly decreased the survival/ proliferation determined by WST-1 absorbance (cleavage of the tetrazolium salt to formazan by cellular mitochondrial dehydrogenases) in the presence or absence of PMA. Figure 5B shows Figure 6A and 6B shows that 2-DG attenuated the zymographic MMP-9 abundance in PMA-induced U937 monocytic cells and in primary murine peritoneal macrophages. In addition, 2-DG attenuated the protein expressions of GLUT-3 and MCP-1 ( Figure 6C) , and interleukin-1 and interleukin-6 mRNA ( Figure 6D ) induced by PMA in U937 cells. Figure 6E and 6F shows that 2-DG treatment (2 mg/mL) significantly inhibited the latent form of zymographic MMP-2, MMP-9 (P0.01), the active form MMP-9 (P0.05), and interleukin-6 secretion (P0.05) in the ex vivo culture of human AAA tissues.
effects of Glycolysis restriction on Monocyte survival/Proliferation and Adhesion to Vascular endothelial cells
effects of Glycolysis restriction on Zymographic Gelatinase Abundance and inflammatory cytokines in cultured Monocyte/Macrophage and ex Vivo culture of Human AAA
discussion
The goal of this study was to investigate the enhanced glycolytic activity in the pathogenesis of AAA. We demonstrated that glucose metabolism increased in patients with AAA and was related to MMP-9 activity. We also report that the glycolysis restriction with intraperitoneal 2-DG administration to the experimental murine models attenuated the aneurysm development. Finally, we demonstrated that potential mechanisms of glycolysis restriction to attenuate the AAA development include the inhibitions of macrophage survival/ proliferation, extracellular matrix-degrading enzyme activity, and macrophage-mediated vascular inflammation.
Glucose analogue FDG is transported into cells that are active in glucose metabolism; however, the inability of FDG to pass along the glycolytic pathway leads to intracellular accumulation. Based on the molecular basis, PET/computed tomography with 18F-FDG has increasingly being used for determining staging and monitoring in patients with different types of cancers. 20 Activated inflammatory/immune cells also exhibit a substantial increase in glucose metabolism, showing similar 18F-FDG uptake in certain inflammatory disorders. 21 However, underlying molecular mechanisms by which the glycolytic activity in immunocompetent cells contributes to the pathogenesis have not been determined. In this study, we highlight that AAA patients had a tendency toward increased 18F-FDG throughout nondilated sites of the aorta and carotid arteries compared with age-matched control subjects, implying that the entire vascular tree exhibits the enhanced glucose metabolism, and the aneurysmal formation assumes to be a focal manifestation of a systemic condition. 22, 23 Further increased 18F-FDG uptake into the abdominal aneurysmal wall suggests enhanced glycolysis of constituent cell's capacity to incorporate glucose to meet energy demand. Aneurysmal process has been reported to extend into 1 or both common iliac arteries in 25% of the AAA cases. 24 We encountered 33% (6/17 cases) of iliac artery aneurysm in this study, and the 18F-FDG uptake assessed by SUVmax was not significantly different between the patients with iliac artery aneurysm and those without having it (SUVmax 3.09±0.27 versus 2.86±0. 31, P0.465) . Although the numbers analyzed were small, our data suggest that glycolysis is likely to be more prominent in abdominal aorta than in iliac artery in the pathogenesis of aneurysmal formation.
Glucose is mostly taken up from interstitial fluid mediated by a family of passive, facilitative GLUT. 4 The magnitude of GLUT-1 and GLUT-3 expression has been reported to be associated with the extent of PET accumulation and disease severity in various types of cancers. [25] [26] [27] [28] [29] Our data suggest that GLUT-1 together with GLUT-3 appear to be the most important isoforms for understanding 18F-FDG uptake in AAA. GLUT-1 is the major isoform found in most cells, whereas GLUT-3 leads to a substantial increase in energy needs associated with cell activation by its high affinity for glucose 30 and is a major GLUT subtype for macrophages. [31] [32] [33] Both GLUT-1 and GLUT-3 immunoreactivity were shown to be distributed in macrophages of the aneurysmal wall, indicating that glycolysis is the preferred energy production of these cells than the other cell types constituted of aorta. Importantly, the magnitude of GLUT-3 expression was associated with MMP-9 activity, mainly produced from macrophages in aneurysmal tissues, 34 and this was comparable in a monocytic cell line, showing the substantial increase in syntheses in GLUT-3 and MMP-9 upon the differentiation to macrophages. This also suggests that macrophages have more GLUT-3 and are metabolically active than monocytes, resulting in producing abundant MMP-9. As high tissue MMP-9 activity has been suggested to be associated with the progression of AAA and its rupture, 9 this metabolic feature led to the hypothesis that inhibition of GLUT expression and restriction of glycolytic pathway could attenuate the progression of AAA. Selective inhibition of either GLUT-1 or GLUT-3 mRNA by RNA interference did not affect the MMP-9 activity in monocytic cell line (data not shown). However, we found that glycolysis restriction with 2-DG effectively decreased the MMP-9 activity in cultured monocytic cells, and this extended to the 2 types of murine AAA models, showing that intraperitoneal administration of 2-DG decreased the MMP-9 activity, accompanied by the inhibition of inflammatory cells infiltration and the expressions of GLUT-3 and MCP-1, resulting in attenuating the aneurysmal formation. In an apolipoprotein E knockout mice infused by angiotensin II, 35 GLUT-1 expression decreased with time regardless of aneurysm formation, whereas the magnitude of GLUT-3 expression was dependent on the aneurysm development. The effect of 2-DG on aneurysm development in this model was much lesser compared with the CaCl 2 -induced models, probably attributable to the different mechanisms to AAA development; CaCl 2 -induced model exhibits the prominent adventitial inflammation, whereas medial dissection precedes the aneurysmal formation in the other one. 36 Inhibition of aneurysmal formation by the 2-DG administration in AAA models would have multiple protective aspects to attenuate the disease progression by acting on macrophages, but also on the other constituted cells in the aortic wall. First, 2-DG attenuated the survival/proliferation of monocytic cells, and this might have reduced the accumulation of inflammatory cells to the adventitial layer of aorta in mice. Second, 2-DG would have directly influenced the MMP-9 activity and the macrophage-mediated vascular inflammation by inhibiting the productions of interleukin-6 and MCP-1 in the aortic wall. 37 DNA microarray complemented that 2-DG led to the multiple modulation of gene expression profiling associated with inflammation, extracellular matrix, and longevity ( Figure VA and VB in the onlineonly Data Supplement). It is important to note that 2-DG not only downregulated gene expressions but also increased expressions such as sirtuin-1 and peroxisome proliferator-activated receptor  coactivator-1, which interact with MMP-9 38 and MCP-1. 39 Third, established human AAA exhibits the high intensity of vasa vasorum, 40, 41 and it may function as a conduit for the entry of inflammatory cells into the aneurysmal wall. Finding in coculture of monocytic cells with vascular endothelial cells suggests that 2-DG administration to the mice might also have affected the adventitial inflammation by inhibiting the endothelial cell activation, resulting in attenuating the monocyte adherence with subsequent subendothelial migration. Not only MMPs but also cysteine proteinases, cathepsins K and S are suggested to be involved in the pathogenesis of AAA 42 ; but, their contribution seems to be less with regard to the glycolysis in this study (Figure VIA-VIG in the online-only Data Supplement). Further studies are clearly warranted to advance the clinical application, and we hypothesize that glycolysis restriction might be effective not only to attenuate the development of AAA but also to regress/stabilize the preexisting AAA by inactivating vascular inflammation, as shown in ex vivo culture of established human AAA. In addition, it is necessary to evaluate any potential side effects of glycolysis restriction, especially in immune and nervous system (Figure VIIA-VIIC in the online-only Data Supplement).
In summary, this study underscores the important role for glycolytic activity in the pathogenesis of aneurysm development. In addition, this finding may offer a conceptual insight into the therapeutic approach targeting inhibition of the glycolytic pathway of aortic walls to treat patients with AAA. Figure 6 . A and B, Effect of 2-deoxyglucose (DG) on zymographic gelatinase abundance in U937 human monocytic cell line (A) and in primary peritoneal mouse macrophages (B). In U937 human monocytic cell line, conditioned medium was collected following 10 nmol/L phorbol 12-myristate 13-acetate (PMA) stimulation with or without 2-DG for 24 hours. Primary murine peritoneal macrophages collected by intraperitoneal injection of 3% thioglycollate were cultured in serum-free medium with or without 2-DG for 24 hours, and the conditioned medium was collected. C and D, Effects of 2-DG on protein expressions of glucose transporter (GLUT)-3, monocyte chemotactic protein (MCP)-1 (C) and gene expressions of interleukin (IL)-1 and IL-6 (D) in U937 human monocytic cell line. The cells were collected following 10 nmol/L PMA stimulation with or without 2-DG for 24 hours. E and F, Effects of 2-DG on zymographic gelatinase abundance (E) and IL-1 and IL-6 secretion (F) in ex vivo culture of human abdominal aortic aneurysm. Conditioned medium collected in the first 24 hours was considered an internal control and those obtained by 96 hours by replacing the medium every 48 hours were used for analysis. Open and closed columns indicate ex vivo culture without or with 2-DG (2 mg/mL), respectively. Data are expressed as the means±SEM (n4-5 for A-D; n6 for E and F). Silver staining was used as the protein-loading control (A and B) and -actin was used to standardize the respective gene/protein expressions (C and D). *P,0.05, **P,0.01 vs control cells; # P,0.05, ## P,0.01 vs PMA without inhibitors. OI indicates optical intensity; L latent form; A, active form.
